Clinical Trials Logo

Clinical Trial Summary

The investigators adopted the CAMS(Chinese Academy of Medical Sciences)-2009 trial for pediatric acute myeloid leukemia (AML) patients between 2009 to 2015, in which a risk-stratified strategy and dose-dense intensive chemotherapy were introduced. The outcomes of CAMS-2009 trial were retrospectively analyzed, and compared to the CAMS-2005 trial.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03165851
Study type Observational
Source Institute of Hematology & Blood Diseases Hospital
Contact
Status Completed
Phase N/A
Start date April 10, 2005
Completion date December 31, 2015

See also
  Status Clinical Trial Phase
Recruiting NCT06158828 - Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML Phase 1/Phase 2
Recruiting NCT04678336 - CD123 Redirected T Cells for AML in Pediatric Subjects Phase 1